Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...

Moderna announced that the FDA agreed to review its application for a mRNA-based flu vaccine after it agreed to further study ...

Moderna’s stock was surging after the FDA said it would review the biotech’s flu-vaccine candidate, a week after it had refused to do so.

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” ...

Scientists develop universal vaccine to protect against allergies, cold and flu - The vaccine could replace multiple jabs ...

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced ...

Moderna says the U.S. Food and Drug Administration (FDA) has agreed to review its influenza ‌vaccine, reversing an earlier decision to reject the application, following modifications from the company.

The Food and Drug Administration’s recent decision to turn away Moderna’s application for a new flu shot for older Americans is a troubling development in health officials’ piecemeal dismantling of ...

The FDA has set a deadline of August to decide on whether to approve the vaccine. Read more at straitstimes.com. Read more at ...